Supplementary Figure Legends
Figure S1: Screening of siRNA for OMA1 knockdown. The endogenous levels of OMA1 protein. Whole cell lysates prepared from MCF10A and 21MT1 cells transfected with shRNAs targeted against OMA1 (OMA1Sh2, OMA1Sh3) or scrambled shRNA (scrambled) were subjected to immunoblotting for OMA1 and GAPDH (loading control). Figure S2 . OMA1 depletion in metastatic breast cancer cells promotes filopodia formation. Live phase contrast and fluorescent images of control and OMA1 knockdown (KD) 21MT-1 (OM.21) cells. Unlike the 21MT-1 cells, OM.21 cells exhibited characteristic filopodialike structures after overgrowth. 21MT-1 and OM.21 cells were stained for Actin with Alexa Fluor 488-conjugated phalloidin and Nuclei with Hoeschst (blue) imaged by confocal microscopy actin. Scale bar, 20 µm.
Figure S3. OMA1 deficiency enhances invasiveness of breast cancer cells by inducing epithelial to mesenchymal transition (EMT) (A)
Representative western blot of extracts from atypical ductal hyperplasia (21PT) cells after transfection with an shRNA scrambled control, and shRNA directed against OMA1. Steady-state levels of the protease were detected by immunoblotting with anti-OMA1 antibody. The GAPDH served as a loading control and was visualized with the respective antibody. (B) Proliferation of control 21PT and OP.21 cells seeded after overgrowth of 7 days at 100% confluence. Data represent the mean ± S.D. of n=3 biological replicates; *p<0.05, ***p<0.001. (C) Live phase contrast images of 21PT cells before and after transfection with OMA1-targeting shRNA at 24h and 48h after seeding in normal culture conditions. Unlike the control 21PT cells, OP.21 cells readily exhibit characteristic filopodia-like structures (marked by black arrows). Scale bar, 20 µm. (D) The prevalence of cells with filopodia-like protrusions was semi-quantitatively analyzed in 21PT and OP.21 cells two days after re-seeding on 6-well plates. Each well was randomly imaged in 3-4 fields of view, each containing 40-75 cells. Of the cells in the field of view the number of cells with long filopodia and cells with filopodia were counted. The data was plotted as a scatter plot wherein each point represents percentage of cells with filopodia of total cells in one field of view. n=3; ***p<0.001. (E) Wound closure assay data detailing the migration of indicated cells out from a confluent monolayer onto a featureless scratch. Representative phase images of control and OP.21 cells are shown. Scale bar, 20 µm. (F) Quantitative analysis of migratory properties of control and OP.21 cells. The extent of wound closure has been calculated as follows: % Wound Closure = [(Area at 0h -Area at 24 or 48h)/ Area at 0h] x 100%. Bars show mean data ± S.D. of 3 biological replicates; ***p<0.001 by unpaired t-test. (G) qRT-PCR analysis of the indicated EMT marker genes expression in control and OP.21 cells after 2 days in culture. The expression levels were normalized to GAPDH transcript and to control cells. Data is presented as mean ± S.D. from 3 biological replicates. *p< 0.05; **p< 0.01; ***p< 0.001 by Student's t-test. -test. (E) The prevalence of cells with protrusions was analyzed in 21MT-1 and OM.21 cells two days after reseeding on 6-well plates. Each well was randomly imaged in 3-4 fields of view, each containing 40-75 cells. Of the cells in the field of view the number of cells with filopodia-like protrusions were counted. The data was plotted as a scatter plot where each point represents the average filopodia size of total cells in one field of view.
Figure S5. Mitochondrial membrane potential is decreased in OMA1-deleted MEF cells.
Representative flow cytometry analysis histograms of control and oma1 -/-MEF cells incubated with 50 nM TMRM under basal, and CCCP-induced uncoupling conditions. 50,000 cells were assayed for TMRM fluorescence in each experiment. 
